Valneva SE/ FR0004056851 /
2024-10-08 5:35:23 PM | Chg. -0.010 | Volume | Bid5:40:00 PM | Ask5:40:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
2.636EUR | -0.38% | 251,417 Turnover: 662,091.270 |
2.630Bid Size: 20 | 2.658Ask Size: 130 | 257.32 mill.EUR | 0.00% | - |
GlobeNewswire
09-03
Valneva and Pfizer Report Further Positive Phase 2 Booster Results for Lyme Disease Vaccine Candidat...
GlobeNewswire
08-01
Valneva and LimmaTech Enter into a Strategic Partnership to Accelerate the Development of the World’...
GlobeNewswire
07-22
CEPI Expands Partnership with Valneva with a $41.3 Million Grant to Support Broader Access to the Wo...
GlobeNewswire
07-17
Phase 3 VALOR Lyme Disease Trial: Valneva and Pfizer Announce Primary Vaccination Series Completion ...
GlobeNewswire
07-01
Valneva Receives Marketing Authorization in Europe for the World’s First Chikungunya Vaccine, IXCHIQ...
GlobeNewswire
06-26
Valneva Announces Successful Outcome of its Combined General Meeting and Appointment of a New Direct...
GlobeNewswire
06-24
Valneva Announces Health Canada Approval of the World’s First Chikungunya Vaccine, IXCHIQ®
GlobeNewswire
06-05
Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Co...
GlobeNewswire
06-03
Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious Diseases
GlobeNewswire
05-13
Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya...
GlobeNewswire
05-07
Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates
GlobeNewswire
03-25
Valneva Announces Filing of 2023 Universal Registration Document and US Form 20-F
GlobeNewswire
03-21
Valneva to Present on its Chikungunya Vaccine IXCHIQ®, Participate in Multiple Events at the 24th Wo...
GlobeNewswire
03-20
Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlook
GlobeNewswire
03-18
Valneva Announces Extension of the Interest-Only Period of Its Debt Facility with Deerfield and Orbi...
GlobeNewswire
03-04
Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor Conferences